Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer
Theranostics · 2025
DOI: 10.7150/thno.107213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Ning Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Molecular Recognition and Biosensing, Frontiers Science Center for New …. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Extracellular Vesicles, Biomarkers, Tumor, RNA, Messenger. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Bladder cancer (BC) ranks as one of the most prevalent cancers. Its early diagnosis is clinically essential but remains challenging due to the lack of reliable biomarkers. Extracellular vesicles (EVs) carry abundant biological cargoes from parental cells, rendering them as promising cancer biomarkers. Herein, we revealed that urinary EVs (uEVs) mRNA signature could serve as non-invasive biomarker for the early diagnosis and prognostic assessment for BC.
Methods
Transcriptomic sequencing was conducted to reveal the mRNA signature of EVs collected from normal cell line and different grades of BC cell lines. Candidate EV-mRNA biomarkers were further profiled using clinical urine samples (n = 97, including healthy controls, BC patients and post-surgery BC patients) by RT-qPCR.
Results
Three mRNAs (SRGN, FLI1, and MACROH2A2) within uEV were identified as potential biomarkers for BC, providing an area under the receiver operating characteristic curve (AUC) of 0.973 for BC diagnosis. Moreover, the uEV-mRNA panel could discriminate early-stage BC patients from healthy controls with an AUC of 0.969. Finally, we found that the uEV-mRNAs were significantly down-regulated in the post-surgery urine samples of BC patients.
Conclusions
Given the facile and non-intrusive nature of urine collection, the identified uEV-mRNAs could serve as potential liquid-biopsy biomarkers for the early diagnosis and prognosis of BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Molecular Recognition and Biosensing, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 30007…
- Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
- Department of Urology, Tianjin First Center Hospital, Nankai University, Tianjin 300071, China.
- Department of Intensive Care Unit, Key Laboratory for Critical Care Medicine of the Ministry of Health, Emergency Medicine Research Institute, Tianjin First Center Hospital, Nankai University, Tianjin 300071, China.
Zitieren
APA
Sun, N., Zhang, Z., Yang, X., Li, J., Li, Q., Kang, J., Wei, Y., Yu, X., Du, R., Hong, X., Liu, G., Gao, H., & Liu, D. (2025). Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics. https://doi.org/10.7150/thno.107213
Vancouver
Sun N, Zhang Z, Yang X, Li J, Li Q, Kang J, et al. Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics. 2025. doi:10.7150/thno.107213
BibTeX
@article{Sun2025,
author = {Sun, Ning and Zhang, Zhaowei and Yang, Xiaoqing and Li, Jingqi and Li, Qiang and Kang, Jingjing and Wei, Yongchun and Yu, Xiaoxuan and Du, Rui and Hong, Xiaoqin and Liu, Guangming and Gao, Hongmei and Liu, Dingbin},
title = {Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.107213}
}
EUVIMED